← Leaderboards
Kathryn Tayo Hall
Brigham And Women'S Hospital
$1,099,685
Attributed
$1,099,685
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $178.2K · FY2016–23$200K$150K$100K$50K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,099,685 · 2
By mechanism
K01$920,685 · 1
R03$179,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Til Sturmer$7,698,961
- James Kuang-Jan Liao$22,168,806
- Hadine Joffe$12,089,762
- Elizabeth W Karlson$93,612,751
- Daniel William Cramer$28,464,820
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseS HealthGeneticRandomizedPreventionPlacebosDrug InteractionsGenesComplexPharmaceutical PreparationsCardiovascular Disorder PreventionCause Of DeathPharmacogenomicsCardiovascular DiseasesCardiovascular PhysiologyClinical TrialsEnzymesEventCatecholaminesCandidate Disease GenePathway InteractionsGenome Wide Association StudyAspirinWomen&Apos
Grant awards (8)
Pharmacogenomic effects of scavenger B1 in cardiovascular disease prevention$89,500
R03 · FY2023 · HL · contact PI
Pharmacogenomic effects of scavenger B1 in cardiovascular disease prevention$89,500
R03 · FY2022 · HL · contact PI
Epidemiological, pharmacogenomic and clinical impact of catechol-O-methyltransferase on cardiovascular disease$51,555
K01 · FY2021 · HL · contact PI
Epidemiological, pharmacogenomic and clinical impact of catechol-O-methyltransferase on cardiovascular disease$178,200
K01 · FY2020 · HL · contact PI
Epidemiological, pharmacogenomic and clinical impact of catechol-O-methyltransferase on cardiovascular disease$178,200
K01 · FY2019 · HL · contact PI
Epidemiological, pharmacogenomic and clinical impact of catechol-O-methyltransferase on cardiovascular disease$178,200
K01 · FY2018 · HL · contact PI
Epidemiological, pharmacogenomic and clinical impact of catechol-O-methyltransferase on cardiovascular disease$178,200
K01 · FY2017 · HL · contact PI
Epidemiological, pharmacogenomic and clinical impact of catechol-O-methyltransferase on cardiovascular disease$156,330
K01 · FY2016 · HL · contact PI